Clinical Trial Update: Dapagliflozin Efficacy and Action in PCOS [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating dapagliflozin for efficacy and action in polycystic ovary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Ovary Syndrome

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Polycystic Ovary Syndrome | Phase 3 | Status: COMPLETED